TELESTA THERAPEUTICS INC T.TST

Today

[NYYANKEE]

Today's FDA meeting was a lesson into why you can't predict. IMHO it became clear the single arm limited P3 results was the issue for the no vote. With such a prevliance of BC it was asked. Why is it so hard to conduct a thorough P3 study. I guess Telesta will hope February brings new life but with such an overwellming no vote it's hard to imagine MCNA will get to market without a another P3. Frankly I think another P3 is needed after listening to the Q & A today. GLTA.

[DamnYankees]

it was an overwhelming no vote in terms of numbers but a reluctant no by many. I realize that the nature of these panels require the participation of an industry's "establishment", but the lack of flexibility and foresight of some was unexpected. The rationale of some of the majority came across as very provinciallly minded and innovation averse, almost defensive of the currently

[tttrident]

I completly agree! It was borderline hostile. Any take on where we go from here ?

[newdaydawning]

Thanks for your guidance. Appears as though downtick could continue, offering bargains to TST newcomers.